Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vaginal microecology refers to the complex and dynamic biological system of the female lower genital tract, which includes the vaginal microbiota, host endocrine environment, local immune defenses, and anatomical structures [2, 14]. A healthy microecological state is typically characterized by low microbial diversity and the dominance of Lactobacillus species, such as L. crispatus, which maintain an acidic environment (pH <4.5) through the production of lactic acid and various antimicrobial compounds [6, 17, 24]. Disruption of this balance, known as dysbiosis, leads to the overgrowth of anaerobic pathogens like Gardnerella vaginalis and Atopobium vaginae, resulting in conditions such as bacterial vaginosis (BV) and increased susceptibility to human papillomavirus (HPV) and other sexually transmitted infections [3, 15, 23]. From a therapeutic perspective, vaginal microecology is treated as a target for restoration using antimicrobial agents to eradicate pathogens and probiotics or vaginal microbiota transplants (VMT) to re-establish beneficial commensal communities [1, 4, 7, 10]. Modern interventions aim to move beyond simple infection management toward precision medicine strategies that stabilize the vaginal ecosystem to prevent reproductive complications and cervical malignancies [1, 10, 16].
Restoration of the vaginal microecology is achieved through the reduction of pathogenic microbial loads using targeted antimicrobials and the replenishment of commensal Lactobacillus species, which acidify the microenvironment and provide competitive inhibition against pathogen colonization [16, 17, 24].
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vaginal microecology.